摘要
有机溶剂 /去污剂处理技术已广泛用于血液制剂的病毒灭活。本文对此项技术用于血浆中病毒灭活的可靠性、处理血液制剂的安全性以及处理血浆的临床应用作了简要介绍。
出处
《微生物学免疫学进展》
2003年第2期83-86,共4页
Progress In Microbiology and Immunology
参考文献12
-
1Neurath AR,Vemon SK, Dobkin MB, et al. Characterization of subviral components resulting from treatment of rabies virus with tri(n-butyl)phosphate[J] .J Gen Virol 1972,14:33-48.
-
2Prince AM,Horowitz B,Brotman B, et al. Inactivation of hepatitis B and Hutchinson strain non-A, non-B hepatitis viruses by exposure to Tween 80 and ether[J]. Vox Sang 1984,46:36-43.
-
3Horowitz B, Wiebe ME,Lippin A, et al. Inactivation of viruses in labile blood derivatives, 1. Disruption of lipid-enveloped viruses by tri ( n-butyl ) phosphate detergent combinations [ J ]. Transfusion.1985,25:516-522.
-
4Horowitz B, Bonomo R, Prince AM, et al. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma.[J]. Blood 1992,79:826-831.
-
5Klein HG,Dodd RY,Dzik WH, et 81. Current status of solvent/detergent-treated frozen plasma [J]. Transfusion 1998, 38: 102-107.
-
6Horowitz B. Blood protein derivative viral safety:observations and analysis[J]. Yale J Biol Med 1990,63:361-369.
-
7Horowitz B,Prince AM,Hamman J,et al. Viral safety of solvent/detergent-treated blood products[J]. Blood Coagul Fibrinolysis.1994,5(Suppl 3) :S21-S28.
-
8Williamson LM and Allain JP. Virally inactivated fresh frozen plasma[J]. Vox Sang 1995,69:159-165.
-
9McOmish F, Yap PL, Jordan A, et al. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction[J]. J Clin Microbiol 1993,31 : 323-328.
-
10Horowitz B. Viral inactivation technology: solvent/detergent treatment to improve viral safety of transfused blood products [ J ]. Genetic Engineering News 1999,19 ( 1 ) : 20.
同被引文献22
-
1王剑锋,英志芳,周铁群,邱平,陈震.冻干加热处理凝血因子类制剂的病毒灭活验证[J].微生物学免疫学进展,2005,33(2):29-31. 被引量：3
-
2程文琴,张艳宇,周锡鹏,马平,吕丽萍,许金波.钴^(60)-γ射线辐照法消毒冻干免疫球蛋白的效果观察[J].中国消毒学杂志,2007,24(4):301-305. 被引量：6
-
3Heimburger N, Karges H E. Strategies to produce virus-safe blood derivatives[J]. Curr Stud Hematol Blood Transfus, 1959, 56:23-33.
-
4Bridonnccu P. Liquid pasteurization of an immunoglobulin preparation without stabilizer: Effects on its biological and biochemical properties[J]. Vox Sang, 1996,70(4):203-209.
-
5Simmonds P, Davidson F, Lycett C, et al. Detection of a novel DNA vinls(TTV) in blood donors and blood products[J]. Lancet, 1998,352:191-195.
-
6Korneyeva M, Hotta J, Lebing W, et al. Envelope virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates[J]. Biologicals, 2002, 30:153-162.
-
7Nisini R, Le Moli S, Matricardi P M, et al. A comparative in vitro study of low pH and enzyme treated immunoglobulin preparation for intravenous use[J]. J Clin Lab Immunol, 1989, 29:193-197.
-
8Lundbald J L, Seng R L. Inactivation of lipid-enveloped viruses in proteins by caprylate[J]. Vox Sang, 1991,60:75-81.
-
9Wang J, Mauser A, Chao S F, et al. Virus inactivation and protein recovery in anovel ultraviolet-C reactor[J]. Vox Sanguinis, 2004,86:230-238.
-
10余伟,赵辉,刘文芳.病毒灭活/去除工艺与血液制品病毒安全性[J].中国输血杂志,2009,22(7):606-610. 被引量：18
二级引证文献20
-
1王智,黄梦,黄云霞,罗志,夏苏,张智.低pH孵放对免疫抑制剂抗人T细胞猪免疫球蛋白病毒灭活效果的验证[J].微生物学免疫学进展,2022,50(6):25-31.
-
2朱海仑.审时度势 抢抓机遇 积极投身国家西部大开发[J].决策通讯,2000(4):8-10.
-
3于洋,孟庆杰.浅谈影响血液制品质量和安全的因素及对策[J].科技创新与应用,2014,4(2):286-286. 被引量：4
-
4李岳飞,刘艳秋,王智鼎,宋艳,孙德军.干热法对猪凝血酶的病毒灭活效果及其对凝血酶活性影响的评价[J].中国输血杂志,2013,26(12):1205-1208. 被引量：4
-
5李凤霞,初云海,黄清玲,李宏伟.脑蛋白水解物溶液的灭活/去除病毒工艺研究[J].中国基层医药,2015,22(1):54-56.
-
6赫玉兰,卢士玲,吴亚楠,王琦翔,田盼.响应面优化超声波法提取牛血红蛋白工艺[J].食品工业科技,2015,36(10):259-263. 被引量：5
-
7黄捷,王炳,卢奎林,陈品全,刘素芳,高荣.预过滤系统对静注人免疫球蛋白纳米过滤的效率和质量影响[J].生物技术世界,2016,13(2):13-14. 被引量：1
-
8李敏.中国血液制品行业分析[J].中国生物工程杂志,2016,36(9):119-125. 被引量：6
-
9吴炜誉,王炳,张伟,张良,黄捷,江砚芳,郑丰平.两种纳米膜过滤对静注人免疫球蛋白生产效率及质量的影响[J].国际生物制品学杂志,2017,40(4):165-168.
-
10黄洁.血液制品工艺设计探讨及工程设计要点[J].化工与医药工程,2017,38(5):33-37. 被引量：1
-
1倪道明.血液制剂的病毒安全性问题及其对策[J].中国输血杂志,1993,6(4):222-226. 被引量：9
-
2李振平.提高血液制品病毒安全性的途径[J].微生物学免疫学进展,1996,24(1):83-85. 被引量：1
-
3张继鹏,周海云.用辛酸盐灭活包膜病毒[J].生物制品快讯,2003(11):23-23.
-
4卢锦汉.生物制品研究进展[J].医药导报,1994,13(5):199-201. 被引量：1
-
5Pier Mannuccio Mannuci,王立兰.凝血因子Ⅷ和Ⅸ浓缩物病毒安全性的临床评价[J].微生物学免疫学进展,1993,21(4):77-80.
-
6SanhuezaS,章建康.国际生物药品的病毒安全性及病毒清除方法评估会议[J].国外医学（预防．诊断．治疗用生物制品分册）,1996,19(5):211-214. 被引量：4
-
7人工授精可避免艾滋病病毒遗传[J].医药世界,2001(11):59-59.
-
8任跃明,程雅琴,倪道明.静脉注射人免疫球蛋白的质量控制[J].中国生物制品学杂志,2005,18(1):73-75. 被引量：12
-
9张玉松,王大燕,徐红,舒跃龙.假病毒的最新应用研究进展[J].医学研究杂志,2008,37(6):116-118. 被引量：6
-
10Mannucci PM,徐进.凝血因子Ⅷ和凝血因子Ⅸ浓缩物病毒安全性的临床评价[J].国外医学（输血及血液学分册）,1993,16(6):355-356.
